CINECA IRIS Institutional Research Information System

AGATE, LAURA Statistiche

AGATE, LAURA  

DIPARTIMENTO DI MEDICINA CLINICA E SPERIMENTALE  

Mostra records
Risultati 1 - 20 di 124 (tempo di esecuzione: 0.051 secondi).
Titolo Data di pubblicazione Autore(i) File
Long-Term Outcome of Patients with Low-Risk Differentiated Thyroid Cancer Treated with Total Thyroidectomy Alone 1-gen-2024 Matrone, Antonio; Faranda, Alessio; Torregrossa, Liborio; Gambale, Carla; Minaldi, Elisa; Prete, Alessandro; De Napoli, Luigi; Rossi, Leonardo; Agate, Laura; Cappagli, Virginia; Puleo, Luciana; Molinaro, Eleonora; Materazzi, Gabriele; Elisei, Rossella
Active surveillance in differentiated thyroid cancer: a strategy applicable to all treatment categories response 1-gen-2023 Campopiano, Maria Cristina; Ghirri, Arianna; Prete, Alessandro; Lorusso, Loredana; Puleo, Luciana; Cappagli, Virginia; Agate, Laura; Bottici, Valeria; Brogioni, Sandra; Gambale, Carla; Minaldi, Elisa; Matrone, Antonio; Elisei, Rossella; Molinaro, Eleonora
Adrenal insufficiency in thyroid cancer patients treated with tyrosine kinase inhibitors and detected by ACTH stimulation test 1-gen-2023 Valerio, L; Giani, C; Matrone, A; Pontillo-Contillo, B; Minaldi, E; Agate, L; Molinaro, E; Elisei, R
Clinical evolution of sporadic medullary thyroid carcinoma with biochemical incomplete response after initial treatment 1-gen-2023 Prete, Alessandro; Gambale, Carla; Torregrossa, Liborio; Ciampi, Raffaele; Romei, Cristina; Ramone, Teresa; Agate, Laura; Bottici, Valeria; Cappagli, Virginia; Molinaro, Eleonora; Materazzi, Gabriele; Elisei, Rossella; Matrone, Antonio
Enlargement of a metastatic lymph node from differentiated thyroid cancer after COVID-19 vaccination 1-gen-2023 Valerio, L.; Prete, A.; Santini, F.; Agate, L.; Elisei, R.; Latrofa, F.
Predictive factors for central neck compartment lymphnodes metastases' in sporadic medullary thyroid cancer patients 1-gen-2023 Cappagli, Virginia; Matrone, Antonio; Piaggi, Paolo; Bottici, Valeria; Agate, Laura; Molinaro, Eleonora; Torregrossa, Liborio; Elisei, Rossella
Pros and cons of an aggressive initial treatment with surgery and radioiodine treatment in minimally invasive follicular thyroid carcinoma 1-gen-2023 Minaldi, Elisa; Giani, Carlotta; Agate, Laura; Molinaro, Eleonora; Elisei, Rossella
Radio-iodine refractory thyroid cancer patients: a tailored follow-up based on clinicopathological features 1-gen-2023 Lorusso, L.; Minaldi, E.; Esposito, G.; Piaggi, P.; Bottici, V.; Brogioni, S.; Giani, C.; Valerio, L.; Molinaro, E.; Elisei, R.; Agate, L.
Significance of Thyroglobulin Autoantibodies in Patients With Thyroid Cancer Treated With Lenvatinib 1-gen-2023 Sgrò, Daniele; Rossi, Piercarlo; Piaggi, Paolo; Brancatella, Alessandro; Lorusso, Loredana; Bottici, Valeria; Molinaro, Eleonora; Latrofa, Francesco; Elisei, Rossella; Agate, Laura
Thyroid autoimmunity, thyroglobulin autoantibodies and thyroid cancer prognosis 1-gen-2023 Viola, Nicola; Agate, Laura; Caprio, Sonia; Lorusso, Loredana; Brancatella, Alessandro; Ricci, Debora; Sgrò, Daniele; Ugolini, Clara; Piaggi, Paolo; Vitti, Paolo; Elisei, Rossella; Santini, Ferruccio; Latrofa, Francesco
Nutrition in Advanced Thyroid Cancer Patients 1-gen-2022 Agate, Laura; Minaldi, Elisa; Basolo, Alessio; Angeli, Valentina; Jaccheri, Roberta; Santini, Ferruccio; Elisei, Rossella
Yttrium-90 transarterial radioembolization for liver metastases from medullary thyroid cancer 1-gen-2022 Puleo, Luciana; Agate, Laura; Bargellini, Irene; Boni, Giuseppe; Piaggi, Paolo; Traino, Claudio; Depalo, Tommaso; Lorenzoni, Giulia; Bianchi, Francesca; Volterrani, Duccio; Brogioni, Sandra; Bottici, Valeria; Brunetto, Maurizia Rossana; Coco, Barbara; Molinaro, Eleonora; Elisei, Rossella
Active surveillance in ret gene carriers belonging to families with multiple endocrine neoplasia 1-gen-2021 Prete, A.; Matrone, A.; Gambale, C.; Bottici, V.; Cappagli, V.; Romei, C.; Torregrossa, L.; Valerio, L.; Minaldi, E.; Campopiano, M. C.; Lorusso, L.; Agate, L.; Molinaro, E.; Viola, D.; Ramone, T.; Mule, C.; Ciampi, R.; Basolo, F.; Elisei, R.
Assessing mPTC Progression during Active Surveillance: Volume or Diameter Increase? 1-gen-2021 Campopiano, Maria Cristina; Matrone, Antonio; Rago, Teresa; Scutari, Maria; Prete, Alessandro; Agate, Laura; Piaggi, Paolo; Elisei, Rossella; Molinaro, Eleonora
Ca19.9 positivity and doubling time are prognostic factors of mortality in patients with advanced medullary thyroid cancer with no evidence of structural disease progression according to RECIST 1-gen-2021 Lorusso, Loredana; Romei, Cristina; Piaggi, Paolo; Fustini, Chiara; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Viola, David; Pellegrini, Giovanni; Elisei, Rossella
Correction to: Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer (Journal of Endocrinological Investigation, (2021), 44, 10, (2139-2151), 10.1007/s40618-020-01491-3) 1-gen-2021 Matrone, A.; Prete, A.; Nervo, A.; Ragni, A.; Agate, L.; Molinaro, E.; Giani, C.; Valerio, L.; Minaldi, E.; Piovesan, A.; Elisei, R.
Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer 1-gen-2021 Matrone, A; Prete, A; Nervo, A; Ragni, A; Agate, L; Molinaro, E; Giani, C; Valerio, L; Minaldi, E; Piovesan, A; Elisei, R
Osteonecrosis of the jaw: a rare but possible side effect in thyroid cancer patients treated with tyrosine-kinase inhibitors and bisphosphonates 1-gen-2021 Lorusso, L.; Pieruzzi, L.; Gabriele, M.; Nisi, M.; Viola, D.; Molinaro, E.; Bottici, V.; Elisei, R.; Agate, L.
Prevalence and Risk Factors of Developing Fistula or Organ Perforation in Patients Treated with Lenvatinib for Radioiodine-Refractory Thyroid Cancer 1-gen-2021 Valerio, L.; Giani, C.; Agate, L.; Molinaro, E.; Viola, D.; Bottici, V.; Matrone, A.; Puleo, L.; Lorusso, L.; Cappagli, V.; Ribechini, A.; Elisei, R.
Thyroid cancer and COVID-19: experience at one single thyroid disease referral center 1-gen-2021 Prete, A.; Falcone, M.; Bottici, V.; Giani, C.; Tiseo, G.; Agate, L.; Matrone, A.; Cappagli, V.; Valerio, L.; Lorusso, L.; Minaldi, E.; Molinaro, E.; Elisei, R.